              |
 |
||
|
||
 |
|
|
|||
 |
 |
||
| - Each capsule contains - Efexor XR 37.5mg: Venlafaxine HCI………………………. 37.5mg Efexor XR 75mg: Venlafaxine HCI………………………..75mg Efexor XR 150mg: Venlafaxine HCI……………………….150mg |
|
||
 |
|||
| - The world's first SNRI for first-line therapy - Excellent medical treatment rate for depression with dual action of Serotonin and Norepinephrine - Superiority in safety and drug tolerance - Low potential for drug -drug interaction - Excellent dosing flexibility - Superior remission rate - The only antidepressant indicated for Generalized Anxiety Disorder - Convenient administration as a single dose per day - Decrease manifestation rate over Nausea |
|||
 |
|||
| Treatment of depression and Generalized Anxiety Disorder (GAD) | |||
 |
|||
| - The recommended starting dose: 75 mg/day, administered
in a single dose. - For some patients, it may be desirable to start at 37.5 mg/day for 4 to 7 days, to allow new patients to adjust to the medication before increasing to 75 mg/day. - If after several weeks further clinical improvement is required, the dose may be increased to 150mg per day given in two divided doses. Patients not responding to the initial 75mg/day dose may benefit from dose increases to a maximum of approximately 225 mg/day. - Dose increases should be in increments of up to 75 mg/day, as needed, and should be made at intervals of not less than 4 days, since steady state plasma levels of venlafaxine and its major metabolites are achieved in most patients by day 4. |
|||
 |
|||
| 100 caps. | |||
|
About Wyeth China | Careers at Wyeth China | Wyeth Worldwide
|
|||
